Naoko Yagishita Selected Research

Naoko Yagishita Research Topics

Disease

7	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022 - 01/2013
4	Inflammation (Inflammations) 01/2021 - 09/2013
4	Spinal Cord Diseases 01/2021 - 01/2015
4	Infections 01/2021 - 01/2011
4	Rheumatoid Arthritis 12/2018 - 02/2008
3	T-Cell Leukemia (Leukemia, T Cell) 01/2021 - 01/2019
3	Disease Progression 01/2021 - 01/2013
3	Fibrosis (Cirrhosis) 12/2018 - 01/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2018 - 10/2010
3	Joint Diseases (Joint Disease) 02/2008 - 10/2003
2	Body Weight (Weight, Body) 01/2018 - 04/2015
1	Overactive Urinary Bladder (Overactive Bladder) 01/2021
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2020
1	Herpes Zoster 10/2019
1	Neoplasms (Cancer) 10/2019
1	Persistent Infection 10/2019
1	Obesity 12/2018
1	Metabolic Diseases (Metabolic Disease) 12/2018
1	Hyperplasia 12/2017
1	Weight Gain 04/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2015
1	Adenocarcinoma of Lung 01/2015
1	Liver Diseases (Liver Disease) 04/2014
1	Experimental Arthritis 12/2011
1	Necrosis 01/2011
1	Osteoarthritis 01/2011

Drug/Important Bio-Agent (IBA)

8	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2018 - 10/2003
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 12/2017 - 03/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 01/2021
2	NeopterinIBA 01/2020 - 01/2013
2	SteroidsIBA 01/2020 - 10/2019
2	ChemokinesIBA 01/2019 - 09/2013
2	mogamulizumabIBA 01/2018 - 01/2015
2	LS-102IBA 04/2015 - 01/2015
2	CollagenIBA 01/2015 - 10/2010
2	Small Interfering RNA (siRNA)IBA 12/2011 - 01/2011
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2021
1	mirabegronIBA 01/2021
1	Cell Adhesion Molecule-1IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	Viral DNAIBA 10/2019
1	Pharmaceutical PreparationsIBA 12/2018
1	CytokinesIBA 12/2017
1	Prednisolone (Predate)FDA LinkGeneric 10/2017
1	Protein CIBA 01/2015
1	Surface-Active Agents (Surfactants)IBA 01/2015
1	Extracellular Matrix ProteinsIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 08/2014
1	Viral ProteinsIBA 08/2014
1	AntioxidantsIBA 04/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014
1	Chemokine CXCL10IBA 01/2013
1	AntibodiesIBA 12/2011
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 12/2011
1	Polysaccharides (Glycans)IBA 01/2011
1	ProstaglandinsIBA 01/2011
1	fucoidanIBA 01/2011
1	Collagenases (Collagenase)FDA Link 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 01/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2011
1	butaprostIBA 01/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2011
1	LuciferasesIBA 01/2011
1	EnzymesIBA 10/2003

Therapy/Procedure

2	Therapeutics 12/2022 - 01/2019